50,711 results on '"*GENERIC products"'
Search Results
2. Comparison of the effectiveness of rabeprazole original and generic products in the monotherapy of gastroesophageal reflux disease
3. Reports Summarize Life Science Findings from National Institutes of Health Sciences (Analysis of Factors Related To Variation In Dissolution Profiles Estimated From Continuously Conducted Dissolution Tests of Generic Products)
4. Update on the advances and challenges in bioequivalence testing methods for complex topical generic products
5. [Comparison of Preparation Efficiency and Therapeutic Safety between Brand-Name and Generic Products of Pemetrexed].
6. Common Deficiencies Found in the Active Pharmaceutical Ingredient (API) Section of Non-sterile Generic Products Submitted for Registration by SAHPRA
7. Application of physiologically based absorption and pharmacokinetic modeling in the development process of oral modified release generic products.
8. Current regulatory scenario and alternative surrogate methods to establish bioequivalence of topical generic products
9. Update on the advances and challenges in bioequivalence testing methods for complex topical generic products.
10. Analysis of Factors Related to Variation in Dissolution Profiles Estimated from Continuously Conducted Dissolution Tests of Generic Products.
11. Dissolution Profiles of Generic Products in Dissolution Media Defined by Japanese Guidelines for Bioequivalence Studies
12. Hot-Melt Extrusion-Based Dexamethasone–PLGA Implants: Physicochemical, Physicomechanical, and Surface Morphological Properties and In Vitro Release Corrected for Drug Degradation.
13. Generic Products Evaluation
14. Generic Products
15. Bioequivalence Studies: Generic Products
16. Pharmacies and drugstores must stock 30% of generic products
17. [Comparison of the effectiveness of rabeprazole original and generic products in the monotherapy of gastroesophageal reflux disease].
18. Discussion of EMA Draft Guideline on Quality and Equivalence of Topical Products Based on Comparison of Approved Mometasone Furoate Drugs.
19. Physiologically‐based pharmacokinetic modeling to support bioequivalence and approval of generic products: A case for diclofenac sodium topical gel, 1%
20. Efficacy and Quality of Antibacterial Generic Products Approved for Human Use: A Systematic Review
21. Study Data from National Taiwan University Update Knowledge of Food and Drug Analysis (Regulatory Considerations for Generic Products of Non-biological Complex Drugs)
22. Complex Generic Products: Insight of Current Regulatory Frameworks in US, EU and Canada and the Need of Harmonisation
23. In vitro comparative quality assessment of different brands of hydrochlorothiazide tablets marketed in Northeast Ethiopia.
24. Approval of Topical Ophthalmic Generic Products in the USA: Simple to Complex Dosage Forms and Establishing Equivalency
25. Bioequivalence Studies: Generic Products
26. Complex Generic Products: Insight of Current Regulatory Frameworks in US, EU and Canada and the Need of Harmonisation
27. In vivo pharmacodynamics of piperacillin/tazobactam: implications for antimicrobial efficacy and resistance suppression with innovator and generic products
28. ケトプロフェン貼付剤の先発医薬品及び後発医薬品の臨床における同等性の検討.
29. Two companies blocked from comparing their generic products to Herceptin in India
30. Comparison of solubility profiles for pioneer and generic monensin premixes in biorelevant simulated intestinal fluid based on shake flask extractions.
31. Regulatory considerations for generic products of non-biological complex drugs.
32. Niche products, generic products, and consumer search
33. Bioequivalence of topical generic products. Part 1: Where are we now?
34. Regulatory considerations for generic products of non-biological complex drugs.
35. Topical Semisolid Drug Product Critical Quality Attributes with Relevance to Cutaneous Bioavailability and Pharmacokinetics: Part I—Bioequivalence of Acyclovir Topical Creams.
36. Pseudo-Generic Products and Barriers to Entry in Pharmaceutical Markets
37. A Survey of the Regulatory Requirements for the Waiver of In Vivo Bioequivalence Studies of Generic Products in Certain Dosage Forms by Participating Regulators and Organisations of the International Pharmaceutical Regulators Programme
38. Data from University of Florida Advance Knowledge in Pharmaceutical Research (Application of Physiologically Based Absorption and Pharmacokinetic Modeling In the Development Process of Oral Modified Release Generic Products)
39. Comparative study of different meloxicam generic products with the brand product
40. Use of Proprietary Names by Prescribers for Generic Products
41. Physiologically based absorption modeling to predict the bioequivalence of two cilostazol formulations.
42. Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs
43. Amazon's Counterfeit Crimes Unit Files Lawsuits Against Bad Actors Attempting to Use Social Media to Knowingly Sell Counterfeit Luxury Items; Bad actors attempted to evade Amazon's controls by listing generic products while purposefully promoting
44. Log-concavity and log-convexity of series containing multiple Pochhammer symbols.
45. RULING OPENS CALIFORNIA TO LAWSUITS OVER GENERIC PRODUCTS
46. Pseudo-Generic Products and Barriers to Entry in Pharmaceutical Markets: Reply
47. Pseudo-Generic Products and Barriers to Entry in Pharmaceutical Markets: Comment
48. Bioequivalence Common Deficiencies in Generic Products Submitted for Registration to the South African Health Products Regulatory Authority (SAHPRA)
49. Comparison of pull management policies for a divergent process with DDMRP buffers: an industrial case study.
50. In vitro Bioequivalence Study of Five Generic Products and the Innovator Brand of Mebeverine Hydrochloride Extended- Release Capsules in Iran Market.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.